Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
POWERbreathe International develops and sells drug-free, clinically validated breathing training devices that strengthen respiratory muscles, alleviate breathlessness, and enhance athletic performance. Their products are used by patients with chronic respiratory conditions, athletes, and individuals seeking general respiratory health improvement. Clinical studies indicate measurable improvements in inspiratory muscle strength and endurance, exercise tolerance, and reductions in perceived exertion, particularly in COPD, asthma, and post-COVID recovery. The company has recently expanded into digital health with the ActiBreathe app, enabling personalized training plans and real-time performance tracking.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on POWERbreathe International.